Back to Search
Start Over
Red blood cell distribution width predicts mortality of adult patients receiving veno-arterial extracorporeal membrane oxygenation.
- Source :
- Perfusion; Jul2024, Vol. 39 Issue 5, p935-942, 8p
- Publication Year :
- 2024
-
Abstract
- Background: Red blood cell distribution width (RDW) is a numerical measure of the variation in the size of circulating red blood cells. Recently, there is increasing interest in the role of RDW as a biomarker for inflammatory states and as a prognostication tool for a wide range of clinical manifestations. The predictive power of RDW on mortality among patients receiving mechanical circulatory support remains largely unknown. Methods: A retrospective analysis of 281 VA-ECMO patients at a tertiary referral academic hospital from 2009 to 2019 was performed. RDW was dichotomized with RDW-Low <14.5% and RDW-High ≥14.5%. The primary outcome was all-cause mortality at 30 days and 1 year. Cox proportional hazards models were used to examine the association between RDW and the clinical outcomes after adjusting for additional confounders. Results: 281 patients were included in the analysis. There were 121 patients (43%) in the RDW-Low group and 160 patients (57%) in the RDW-High group. Survival to ECMO decannulation [RDW-H: 58% versus RDW-L: 67%, p = 0.07] were similar between the two groups. Patients in RDW-H group had higher 30-days mortality (RDW-H: 67.5% vs RDW-L: 39.7%, p < 0.001) and 1 year mortality (RDW-H: 79.4% vs RDW-L: 52.9%, p < 0.001) compared to patients in the RDW-L group. After adjusting for confounders, Cox proportional hazards model demonstrated that patients with high RDW had increased odds of mortality at 30 days (hazard ratio 1.9, 95% CI 1.2–3.0, p < 0.01) and 1 year (hazard ratio 1.9, 95% CI 1.3–2.8, p < 0.01) compared to patients with low RDW. Conclusions: Among patients receiving mechanical circulatory support with VA-ECMO, a higher RDW was independently associated with increased 30-days and 1-year mortality. RDW may serve as a simple biomarker that can be quickly obtained to help provide risk stratification and predict survival for patients receiving VA-ECMO. [ABSTRACT FROM AUTHOR]
- Subjects :
- MORTALITY risk factors
RISK assessment
ERYTHROCYTES
EXTRACORPOREAL membrane oxygenation
ACADEMIC medical centers
BODY mass index
T-test (Statistics)
QUESTIONNAIRES
KRUSKAL-Wallis Test
FISHER exact test
HEMOGLOBINS
RETROSPECTIVE studies
TERTIARY care
DESCRIPTIVE statistics
AGE distribution
CHI-squared test
TREATMENT duration
BLOOD platelet transfusion
ODDS ratio
MEDICAL records
ACQUISITION of data
STATISTICS
LACTATES
CONVALESCENCE
SURVIVAL analysis (Biometry)
CONFIDENCE intervals
DATA analysis software
BIOMARKERS
PROPORTIONAL hazards models
COMORBIDITY
ADULTS
Subjects
Details
- Language :
- English
- ISSN :
- 02676591
- Volume :
- 39
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- Perfusion
- Publication Type :
- Academic Journal
- Accession number :
- 177990814
- Full Text :
- https://doi.org/10.1177/02676591231169850